ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve

CompletedOBSERVATIONAL
Enrollment

303

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2016

Conditions
Aortic Stenosis
Trial Locations (19)

24105

Universitätsklinikum Kiel - Kardiologie u. Angiologie, Kiel

25030

CH J. Minjoz - Besancon, Besançon

31059

CHU Rangueil - Toulouse, Toulouse

33604

CHU Bordeaux, Bordeaux

35128

Univ. Padova, Azienda Ospedaliera di Padova, Padua

45122

Westdeutsches Herzzentrum Essen - Uniklinikum -, Essen

70376

Robert-Bosch-Hospital Stuttgart, Stuttgart

76031

CHU Rouen, Rouen

81925

Städt. Klinikum München GmbH Herzchirurgie Bogenhausen, München

91349

Institut Jacques Cartier Massy, Massy

Unknown

Cardiac Surgery dpt., Innsbruck Medical University Hospital, Innsbruck

Division of Cardiology, Helsinki University Central Hospital, Helsinki

Hopital Cardio-Vasculaire et Pneumologie Louis Pradel, Lyon

Policlinico San Matteo/Department of Cardiac Surgery, Pavia

Academisch Medisch Centrum, Amsterdam

Rikshospital Oslo, Oslo

Klinika Kardiochirurgii UCK Gdansk, Gdansk

St. Thomas Hospital Cardiothoracic surgery dept, London

James Cook Hospital - Cardiothoracic Division, Middlesbrough

All Listed Sponsors
lead

Institut für Pharmakologie und Präventive Medizin

NETWORK

NCT01991431 - ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve | Biotech Hunter | Biotech Hunter